Pancreatic Cancer Research

ResearcherMedical University of LodzActive in the last 2 years

Izabela Szymczak-Pajor

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6545-579X; OpenAlex author ID A5070814383. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Do We Have Enough Evidence That Metformin Is Superior to Other Antidiabetic Drugs in Pancreatic Cancer Risk Reduction? Co-author DOI 10.3390/ijms27104195↗
  2. Vitamin D Protects Pancreatic Cancer (PC) Cells from Death and DNA Damage Induced by Oxidative Stress. Co-author DOI 10.3390/antiox14091101↗
  3. Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300/CBP-As… Co-author DOI 10.3390/ph16010115↗
  4. A potential role of calpains in sulfonylureas (SUs) -mediated death of human pancreatic cancer cells (1.2B4). Co-author DOI 10.1016/j.tiv.2021.105128↗
  5. Light Stability, Pro-Apoptotic and Genotoxic Properties of Silver (I) Complexes of Metronidazole and 4-Hydroxymethylpyridine against Pancreatic Cancer Cells In… Co-author DOI 10.3390/cancers12123848↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Agnieszka Śliwińska · 5 shared papers, 2020–2026 · strength 1.23
  2. Justyn Ochocki · 1 shared paper, 2020 · strength 0.15
  3. Dominik Żyro · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.